News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
He Junli
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/10/2023 |
4/A
| He Junli (CEO) has filed a Form 4 on Biostage, Inc.
Txns:
| Granted 267,616 options to buy
@ $6.08, valued at
$1.6M
|
|
05/24/2023 |
SC 13G/A
| He Junli has filed a Schedule 13D for Bright Scholar Education Holdings Limited |
01/05/2023 |
4
| He Junli (Director) has filed a Form 4 on Biostage, Inc.
Txns:
| Sold 135 shares
@ $6.83, valued at
$922.1 |
|
07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/11/2022 |
SC 13G/A
| He Junli reports a 4.7% stake in Bright Scholar Education Holdings Limited |
11/10/2021 |
4
| He Junli (Director) has filed a Form 4 on Biostage, Inc.
Txns:
| Granted 10,895 options to buy
@ $2.75, valued at
$30k
Granted 8,727 options to buy
@ $2.75, valued at
$24k
|
|
11/10/2021 |
3
| He Junli (Director) has filed a Form 3 on Biostage, Inc. |
01/25/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
01/21/2020 |
SC 13G/A
| He Junli reports a 4.9% stake in Bright Scholar Education Holdings Limited |
02/07/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
|
|